ANALYST-DOWNGRADE ·Filed Sep 30, 2026
Citigroup double downgrade: Neutral → Sell
Price Chart
Loading chart...
Executive Summary
Citigroup double downgrade: Neutral → Sell
Impact Score
Base Score
4/7
LLM Adjustment
+0
Final Score
4/10
Consensus & Targets
Buy / Strong Buy
11 (37%)
Hold
17
Sell / Strong Sell
2
Total Analysts
18
Mean PT
$119.56
Median PT
$125.00
High PT
$170.00
Low PT
$45.00
Current Price
$203.46
Implied Upside
-41.2%
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-30 | Citigroup | downgrade | Sell | $80.00 |
| 2026-09-03 | Rothschild & Co | downgrade | Sell | $81.00 |
| 2026-08-28 | Argus Research | upgrade | Buy | — |
| 2026-08-25 | Wolfe Research | upgrade | Peer Perform | — |
| 2026-08-24 | Barclays | maintain | Equal-Weight | $125.00 |
| 2026-08-21 | JP Morgan | maintain | Underweight | $77.00 |
| 2026-08-20 | Goldman Sachs | maintain | Neutral | $120.00 |
| 2026-08-20 | UBS | maintain | Neutral | $150.00 |
| 2026-08-20 | Morgan Stanley | maintain | Equal-Weight | $89.00 |
| 2026-08-19 | William Blair | upgrade | Outperform | — |
Firm Track Record — Citigroup
Citigroup accuracy: 55% on 4354 calls | avg return: 4.9%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 13 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Jefferies | 100% | 2/2 | 42.6% | top tier |
| Morgan Stanley | 75% | 3/4 | 26.9% | top tier |
| B of A Securities | 67% | 2/3 | 10% | top tier |
| Leerink Partners | 50% | 1/2 | 48.9% | below average |
| Citigroup | 50% | 1/2 | 31.7% | below average |
| JP Morgan | 50% | 3/6 | -7.9% | below average |
| RBC Capital | 38% | 3/8 | -7.9% | below average |
| Needham | 38% | 3/8 | -14.3% | below average |
| Barclays | 33% | 2/6 | -7.5% | below average |
| Piper Sandler | 25% | 1/4 | 4.5% | below average |
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $-1.29 | $-3.32 — $-0.53 | $895.0M | ↑2 ↓0 |
| +1q | $-1.74 | $-2.09 — $-0.63 | $667.8M | ↑3 ↓0 |
| 0y | $-8.38 | $-10.55 — $-6.66 | $2.1B | ↑3 ↓0 |
| +1y | $-4.79 | $-7.11 — $-2.73 | $2.4B | ↑2 ↓0 |
Cross-Platform Signals
Insider Trades (90d)
0 buys / 5 sells
Congressional
Maria Elvira Salazar (republican) — sell $1,001 - $15,000
Congressional
Maria Elvira Salazar (republican) — buy $1,001 - $15,000
Institutional
CITADEL ADVISORS LLC — trim (-39.9%)
Institutional
JPMORGAN CHASE & CO — trim (-36.4%)
Institutional
NORGES BANK — new
Short Interest
Short: 4,364,990 | Exempt: 4,642 | TRF Vol: 6,947,377 | Short Ratio: 62.8% | Off-exchange volume (dark pool + OTC)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
18 reports for MRNA
80% Hit rate best @ T+60▲ +14.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 2d ago | ANALYST-DOWNGRADE | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | ANALYST-DOWNGRADE | $148.87 $143.97 | ▲ +3.29% | ▲ +2.14% | $187.38 (−25.87%) |
Aug 31, 2026 4w ago | Court Ruling | $140.19 $140.33 | ▼ −0.10% | ▼ −0.24% | $187.38 (−33.66%) |
Aug 25, 2026 5w ago | ANALYST-UPGRADE | $158.83 $154.27 | ▼ −2.87% | ▼ −2.33% | $187.38 (+17.98%) |
Aug 19, 2026 6w ago | ANALYST-UPGRADE | $174.38 $149.66 | ▼ −14.18% | ▼ −13.79% | $187.38 (+7.45%) |
Aug 5, 2026 8w ago | 144 | $56.26 $63.67 | ▼ −13.18% | ▼ −12.83% | $187.38 (−233.09%) |
Jul 31, 2026 9w ago | 8-K | $54.82 $59.17 | ▲ +7.94% | ▲ +4.42% | $187.38 (+241.81%) |
Jul 10, 2026 11w ago | 3 | $67.01 $61.82 | ▼ −7.75% | ▼ −6.96% | $187.38 (+179.63%) |
Jul 8, 2026 12w ago | 8-K | $73.80 $67.44 | ▼ −8.62% | ▼ −9.48% | $187.38 (+153.90%) |
Jun 18, 2026 15w ago | 144 | $63.96 $59.75 | ▼ −6.58% | ▼ −4.92% | $187.38 (+192.96%) |
Showing 10 of 18
US Market Status
Market Open — Closes in 1h 23m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access